胸腔溢液中的腺氨酸脱胺酶:桥梁诊断和炎症的病理生理学
Dan-Dan Shi1, Ju Tian2, Jing Ding1
1Department of Plastic Surgery, Zhongshan People's Hospital, Zhongshan 528400, Guangdong Province, China.
World journal of clinical cases
|August 7, 2025
概括
腹腺脱氨酶 (P-ADA) 是炎症性腹溢液的可靠生物标志物. 一项研究确定P-ADA切线≥9.00U/L,有助于早期诊断和减少侵入性手术.
科学领域:
- 肺部病理学 肺部病理学
- 生物标志物发现发现
- 诊断医学 诊断医学
背景情况:
- 尽管有先进的成像技术,但区分炎症性和非炎症性外泄仍然具有挑战性.
- 一项回顾性队列研究分析了157名患者,以评估腹腺脱氨酶 (P-ADA) 作为生物标志物.
- 之前的研究缺乏标准化的P-ADA切割值,导致诊断不一致.
相关概念视频
Pleural Effusion I: Introduction
1.8K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
1.8K
Pleural Effusion II: Symptoms and Management
269
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
269
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
Pneumonia II: Pathophysiology
559
The pathophysiology of pneumonia involves the following steps:
559
Pericarditis I: Introduction
23
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
23
Pleural Disorders: Types and Brief Description
298
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
298


